An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.

[1]  T. Eichler.  Radiotherapy for localized prostate cancer. , 2007, The Canadian journal of urology.

[2]  J. Fitzpatrick.  The natural history of benign prostatic hyperplasia , 2006, BJU international.

[3]  N. Agnantis,et al.  Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. , 2004, In vivo.

[4]  Pamela Catton,et al.  Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[5]  A. Nahum,et al.  Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio , 2003 .

[6]  P. V. Van Schil,et al.  Growth index is independent of microvessel density in non-small cell lung carcinomas. , 2003, Human pathology.

[7]  R. Mason,et al.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. , 2003, Neoplasia.

[8]  Jens Overgaard,et al.  Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Ashesh B Jani,et al.  Early prostate cancer: clinical decision-making , 2003, The Lancet.

[10]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[11]  Alexandra L Hanlon,et al.  Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. , 2002, Urology.

[12]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Buttyan,et al.  Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia? , 2002, Current urology reports.

[14]  M Gion,et al.  Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. , 2002, European journal of cancer.

[15]  P. Babb,et al.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons , 2002, BJU international.

[16]  M. Barry,et al.  Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. , 2001, Journal of clinical epidemiology.

[17]  C. West,et al.  Tumor vascularity: a histological measure of angiogenesis and hypoxia. , 2001, Cancer research.

[18]  O. S. Nielsen,et al.  Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.

[19]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[20]  M. Varia,et al.  Semiquantitative immunohistochemical analysis for hypoxia in human tumors. , 2001, International journal of radiation oncology, biology, physics.

[21]  J. Overgaard,et al.  Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[22]  R. Kirby,et al.  The natural history of benign prostatic hyperplasia: what have we learned in the last decade? , 2000, Urology.

[23]  J. D. Chapman,et al.  Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age , 2000, Cancer.

[24]  A. Hanlon,et al.  Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. , 2000 .

[25]  J. Overgaard,et al.  A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.

[27]  G. Arteel,et al.  Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. , 1999, Radiation research.

[28]  P Vaupel,et al.  Modulation of tumor oxygenation. , 1998, International journal of radiation oncology, biology, physics.

[29]  G. Arteel,et al.  Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. , 1998, European journal of biochemistry.

[30]  N. Weidner,et al.  Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.

[31]  J. Overgaard,et al.  Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  J. Brown,et al.  Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation. , 1997, Radiation research.

[33]  H. Lyng,et al.  Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[35]  T K Lewellen,et al.  Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.

[36]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[37]  G. Perry,et al.  Radiotherapy for localized prostate cancer: assessment of results by systematic biopsy and PSA. , 1996, The Canadian journal of urology.

[38]  J. Babb,et al.  Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. , 1995, International journal of radiation oncology, biology, physics.

[39]  M. Brawer,et al.  Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity , 1994, Cancer.

[40]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[41]  M. Brawer,et al.  Comparison of microscopic vascularity in benign and malignant prostate tissue. , 1993, Human pathology.

[42]  T. Schultheiss,et al.  The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy , 1991, Cancer.

[43]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[44]  G. Adams.  The clinical relevance of tumour hypoxia. , 1990, European journal of cancer.

[45]  D P Byar,et al.  Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies , 1972 .

[46]  S. Edge,et al.  Prognostic factors in breast cancer , 2005 .

[47]  M. Benson,et al.  Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells , 2003, The Prostate.

[48]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[49]  C. Aquino-Parsons,et al.  Measuring hypoxia in solid tumours--is there a gold standard? , 2001, Acta oncologica.

[50]  G C Morton,et al.  Early prostate cancer. , 2000, Current problems in cancer.

[51]  R. Kubik-Huch,et al.  CT and MRI of the male genital tract: radiologic–pathologic correlation , 1999, European Radiology.

[52]  A. Hanlon,et al.  Hypoxic regions exist in human prostate carcinoma. , 1999, Urology.

[53]  J. Overgaard,et al.  Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.

[54]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  K. Lee,et al.  Cancer Research Campaign , 1991 .